Key facts
- This page summarizes Athanasios Skarpelos's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Aug 2021, 17:22.
Athanasios Skarpelos - 02 Aug 2021 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)
- Form type
- 4
- Accepted by SEC
- 04 Aug 2021, 17:22:28 UTC
- Next filing
- 27 May 2022
- SEC filing
- View on sec.gov
- Reporting owner signature
- /s/ Athanasios Skarpelos
Source evidence
4 source fields
Reporting owner
1 detail
Key filing fact
Athanasios Skarpelos filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 04 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AVXL
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +25,000
- Change %
- Price
- $0.000000
- Shares after
- 25,000
- Date
- 02 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $18.11
* marks a reported price that did not pass the local price check.